InMode (INMD) Cash from Investing Activities (2018 - 2026)

InMode (INMD) posted quarterly Cash from Investing Activities of $109.1 million for Q1 2026, up 44.54% year-on-year from $75.5 million in Q1 2025, and up 300.78% on a QoQ basis from $27.2 million in Q4 2025.

InMode (INMD) Cash from Investing Activities (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Cash from Investing Activities for 9 consecutive years, with $109.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Investing Activities rose 44.54% year-over-year to $109.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $219.6 million (down 22.95% YoY) and the FY2025 annual result came in at $186.0 million, up 14.69% from the prior year.
  • Cash from Investing Activities rose to $109.1 million in Q1 2026 per INMD's latest filing, from $27.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for INMD reached as high as $114.1 million in Q3 2024 and fell as low as -$69.8 million in Q3 2023.
  • A 5-year average of $12.5 million and a median of $11.7 million in 2025 frame the typical range for Cash from Investing Activities.
  • The largest YoY upside for Cash from Investing Activities was 647.89% in 2023 against a maximum downside of 117.11% in 2023.
  • Year by year, Cash from Investing Activities stood at -$38.3 million in 2022, then plunged by 34.79% to -$51.6 million in 2023, then jumped by 250.84% to $77.8 million in 2024, then sank by 65.02% to $27.2 million in 2025, then jumped by 300.78% to $109.1 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $109.1 million, $27.2 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 InMode 981,130.50 -479.15 Mn 61.55 Mn 109.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 109.10 Mn
Mar 31, 2026 109.10 Mn
Dec 31, 2025 27.22 Mn
Dec 31, 2025 27.22 Mn
Sep 30, 2025 11.67 Mn
Sep 30, 2025 11.67 Mn
Jun 30, 2025 71.66 Mn
Jun 30, 2025 71.66 Mn
Mar 31, 2025 75.49 Mn
Mar 31, 2025 75.49 Mn
Dec 31, 2024 77.82 Mn
Dec 31, 2024 77.82 Mn
Sep 30, 2024 114.06 Mn
Sep 30, 2024 114.06 Mn
Jun 30, 2024 17.73 Mn
Jun 30, 2024 17.73 Mn
Mar 31, 2024 -47.39 Mn
Mar 31, 2024 -47.39 Mn
Dec 31, 2023 -51.59 Mn
Dec 31, 2023 -51.59 Mn